Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α

Cell Cycle

Volumn 11, Issue 14, 2012, Pages 2681-2690

  Hanse, Eric A ^a,b   Mashek, Douglas G ^c   Becker, Jennifer R ^b   Solmonson, Ashley D ^b   Mullany, Lisa K ^b   Mashek, Mara T ^c   Towle, Howard C ^c   Chau, Anhtung T ^a,b   Albrecht, Jeffrey H ^a,b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cell cycle; Cyclin D1; Cyclins; Hepatocyte nuclear factor 4 alpha; Lipid metabolism; Lipogenesis; Liver regeneration

Indexed keywords

CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GAL4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; GLUCOSE METABOLISM; LIPID METABOLISM; LIPOGENESIS; LIVER CELL; LIVER FUNCTION; LIVER REGENERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84864386776     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21019     Document Type: Article

References (38)

1. Gonzalez FJ. Regulation of hepatocyte nuclear factor 4 α-mediated transcription. Drug Metab Pharmacokinet 2008; 23:2-7; PMID:18305369; http://dx.doi.org/10.2133/dmpk.23.2.
2. Hayhurs tGP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001; 21:1393-403; PMID:11158324; http://dx.doi.org/10.1128/MCB.21.4.1393-403.2001.
3. Yin L, Ma H, Ge X, Edwards PA, Zhang Y. Hepatic hepatocyte nuclear factor 4α is essential for maintaining triglyceride and cholesterol homeostasis. Arterioscler Thromb Vasc Biol 2011; 31:328-36; PMID:21071704; http://dx.doi.org/10.1161/ATVBAHA.110.217828.
4. Martinez-Jimenez CP, Kyrmizi I, Cardot P, Gonzalez FJ, Talianidis I. Hepatocyte nuclear factor 4α coordinates a transcription factor network regulating hepatic fatty acid metabolism. Mol Cell Biol 2010; 30:565-77; PMID:19933841; http://dx.doi.org/10.1128/MCB.00927-09.
5. Postic C, Dentin R, Denechaud PD, Girard J. ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu Rev Nutr 2007; 27:179-92; PMID:17428181; http://dx.doi.org/10.1146/annurev.nutr.27.061406.093618.
6. Ma L, Robinson LN, Towle HC. ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem 2006; 281:28721-30; PMID:16885160; http://dx.doi.org/10.1074/jbc.M601576200.
7. Tsatsos NG, Davies MN, O'Callaghan BL, Towle HC. Identification and function of phosphorylation in the glucose-regulated transcription factor ChREBP. Biochem J 2008; 411:261-70; PMID:18215143; http://dx.doi.org/10.1042/ BJ20071156.
8. Davies MN, O'Callaghan BL, Towle HC. Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity. J Biol Chem 2008; 283:24029-38; PMID:18591247; http://dx.doi.org/10.1074/jbc.M801539200.
9. Li MV, Chang B, Imamura M, Poungvarin N, Chan L. Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. Diabetes 2006; 55:1179-89; PMID:16644671; http://dx.doi.org/10.2337/ db05-0822.
10. Bricambert J, Miranda J, Benhamed F, Girard J, Postic C, Dentin R. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest 2010; 120:4316-31; PMID:21084751; http://dx.doi.org/10.1172/JCI41624.
11. Burke SJ, Collier JJ, Scott DK. cAMP prevents glucose-mediated modifications of histone H3 and recruitment of the RNA polymerase II holoenzyme to the L-PK gene promoter. J Mol Biol 2009; 392:578-88; PMID:19631660; http://dx.doi.org/10.1016/j.jmb.2009.07.053.
12. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43:45-53; PMID:16447274; http://dx.doi.org/10.1002/hep.20969.
13. Albrecht JH, Mullany LK. Cell Cycle Control in the Liver. In: Arias IM, Ed. The Liver: Biology and Pathobiology. Chichester UK.: John Wiley & Sons, Ltd. 2009; 5.
14. Grisham JW. Molecular Biology of Hepatocellular Carcinoma. In: Abbruzzese JL, Evans DB, Willett CG, Fenoglio-Preiser C, Eds. Gastrointestinal Oncology. New York: Oxford University Press 2004; 471-506.
15. Santamaria D, Ortega S. Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci 2006; 11:1164-88; PMID:16146805; http://dx.doi.org/10.2741/1871.
16. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004; 145:5439-47; PMID:15331580; http://dx.doi.org/10.1210/en.2004-0959.
17. Petre-Draviam CE, Williams EB, Burd CJ, Gladden A, Moghadam H, Meller J, et al. A central domain of cyclin D1 mediates nuclear receptor corepressor activity. Oncogene 2005; 24:431-44; PMID:15558026; http://dx.doi.org/10.1038/sj. onc.1208200.
18. Fu M, Wang C, Rao M, Wu X, Bouras T, Zhang X, et al. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem 2005; 280:29728-42; PMID:15951563; http://dx.doi.org/10.1074/jbc. M503188200.
19. Bienvenu F, Jirawatnotai S, Elias JE, Meyer CA, Mizeracka K, Marson A, et al. Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature 2010; 463:374-8; PMID:20090754; http://dx.doi.org/10.1038/nature08684.
20. Bienvenu F, Barré B, Giraud S, Avril S, Coqueret O. Transcriptional regulation by a DNA-associated form of cyclin D1. Mol Biol Cell 2005; 16:1850-8; PMID:15659654; http://dx.doi.org/10.1091/mbc.E04-08-0654.
21. Buchakjian MR, Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 2010; 11:715-27; PMID:20861880; http://dx.doi.org/10.1038/nrm2972.
22. Mullany LK, White P, Hanse EA, Nelsen CJ, Goggin MM, Mullany JE, et al. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle 2008; 7:2215-24; PMID:18635970; http://dx.doi.org/10.4161/cc.7. 14.6274.
23. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994; 91:709-13; PMID:8290586; http://dx.doi.org/10.1073/pnas.91.2.709.
24. Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 2006; 9:13-22; PMID:16413468; http://dx.doi.org/10.1016/j.ccr.2005.12.019.
25. Burke SJ, Collier JJ, Scott DK. cAMP opposes the glucose-mediated induction of the L-PK gene by preventing the recruitment of a complex containing ChREBP, HNF4α and CBP. FASEB J 2009; 23:2855-65; PMID:19406844; http://dx.doi.org/10.1096/fj.08-126631.
26. Adamson AW, Suchankova G, Rufo C, Nakamura MT, Teran-Garcia M, Clarke SD, et al. Hepatocyte nuclear factor-4α contributes to carbohydrate-induced transcriptional activation of hepatic fatty acid synthase. Biochem J 2006; 399:285-95; PMID:16800817; http://dx.doi.org/10.1042/BJ20060659.
27. Newberry EP, Kennedy SM, Xie Y, Luo J, Stanley SE, Semenkovich CF, et al. Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. Hepatology 2008; 48:1097-105; PMID:18697204; http://dx.doi.org/10.1002/hep.22473.
28. Gove CD, Hems DA. Fatty acid synthesis in the regenerating liver of the rat. Biochem J 1978; 170:1-8; PMID:24443.
29. Schofield PS, Sugden MC, Corstorphine CG, Zammit VA. Altered interactions between lipogenesis and fatty acid oxidation in regenerating rat liver. Biochem J 1987; 241:469-74; PMID:3593202.
30. Glende EA Jr, Morgan WS. Alteration in liver lipid and lipid fatty acid composition after partial hepatectomy in the rat. Exp Mol Pathol 1968; 8:190-200; PMID:4296682; http://dx.doi.org/10.1016/0014-4800(68)90015-4.
31. Brasaemle DL. Cell biology. A metabolic push to proliferate. Science 2006; 313:1581-2; PMID:16973864; http://dx.doi.org/10.1126/science.1133253.
32. Gazit V, Weymann A, Hartman E, Finck BN, Hruz PW, Tzekov A, et al. Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology 2010; 52:2109-17; PMID:20967828; http://dx.doi.org/10.1002/hep.23920.
33. Yoshimoto K, Nakamura T, Ichihara A. Reciprocal effects of epidermal growth factor on key lipogenic enzymes in primary cultures of adult rat hepatocytes. Induction of glucose-6-phosphate dehydrogenase and suppression of malic enzyme and lipogenesis. J Biol Chem 1983; 258:12355-60; PMID:6355085.
34. Mullany LK, Hanse EA, Romano A, Blomquist CH, Mason JI, Delvoux B, et al. Cyclin D1 regulates hepatic estrogen and androgen metabolism. Am J Physiol Gastrointest Liver Physiol 2010; 298:884-95; PMID:20338923; http://dx.doi.org/ 10.1152/ajpgi.00471.2009.
35. Thomas G. An encore for ribosome biogenesis in the control of cell proliferation. Nat Cell Biol 2000; 2:71-2; PMID:10806485; http://dx.doi.org/10. 1038/35010581.
36. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, et al. Progression of HCC in mice is associated with a down-regulation in the expression of hepatocyte nuclear factors. Hepatology 2004; 39:1038-47; PMID:15057908; http://dx.doi.org/10.1002/hep.20155.
37. Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4α gene. Hepatology 2008; 48:1528-39; PMID:18925631; http://dx.doi.org/10.1002/hep.22510.
38. Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 2010; 70:7640-51; PMID:20876809; http://dx.doi.org/10.1158/0008-5472.CAN-10- 0824.